CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for China Sky One Medical, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

China Sky One Medical, Inc.
No. 38 Dingxin 3Rd Street
Nangang District, Heilongjiang Province
Phone: +86 45187032617p:+86 45187032617 HAERBIN, HNG  150001  China Fax: +86 45187032619f:+86 45187032619
On 8/15/2014, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of China Sky One Medical, Inc. for failure to make required periodic filings with the Commission
This company is no longer actively traded on any major stock exchange.
Business Summary
China Sky One Medical, Inc., through its subsidiaries, is engaged in the development, manufacture, marketing and sale of over-the-counter, nutritional supplements and over-the-counter plant and herb-based pharmaceutical and medicinal products. The Company’s principal products are external use Traditional Chinese Herbal Remedies/Medicines (TCM). It is an integrated manufacturer, marketer and distributor of external-use TCM products sold primarily in the People’s Republic of China. The Company produces TCM products with several forms of delivery including ointments, sprays, medicated skin patches, injections, capsules, suppositories, tablets and granules. It also develops and sells bio-engineering products in the form of diagnostic kits, which are used for testing for different diseases. The Company’s business is conducted, through its wholly owned subsidiary, American California Pharmaceutical Group, Inc. (ACPG).
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201112/31/2010YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
5122 Drugs, drug proprietaries, and druggists' sundries
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer Yan-qingLiu 47 5/30/2006 5/30/2006
General Manager, Director Jian-pingLi 9/5/2011 9/5/2011
Board Secretary BingLiu 9/5/2011 9/5/2011
4 additional Officers and Directors records available in full report.

Business Names
Business Name
American California Pharmaceutical Group, Inc.
China Sky One Medical, Inc.
Harbin First Bio-Engineering Company Limited
5 additional Business Names available in full report.

General Information
Stock Exchange: OTC
Federal Tax Id: 870430322
Fax Number: +86 45187032619
Email Address: info@comettechnologies.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023